Loading…
US drug delivery company Aptar Pharma acquired the device technology assets of Israeli company SipNose Nasal Delivery Systems for approximately $12.5 million. SipNose, based in Yokneam, has developed a nasal drug delivery system for precise targeting of the nasal cavity.